Literature DB >> 15579479

Case-control analysis of thymidylate synthase polymorphisms and risk of lung cancer.

Qiuling Shi1, Zhengdong Zhang, Ana S Neumann, Guojun Li, Margaret R Spitz, Qingyi Wei.   

Abstract

Although tobacco smoking is the primary risk factor for lung cancer, low dietary folate intake and suboptimal DNA repair capacity also contribute to lung cancer risk. Thymidylate synthase (TYMS) is involved in the metabolism of folate and the provision of nucleotides needed for DNA synthesis and repair. Thus, a variation in TYMS functions likely plays a role in the etiology of lung cancer. The TYMS gene has a tandem repeat polymorphism (two or three 28 bp) in the TYMS enhancer region (TSER) and a 6 bp deletion/insertion polymorphism in the TS 3'-untranslated region (TS3'UTR or 1494del6). We investigated the frequencies of these two polymorphisms in a hospital-based case-control study of 1055 lung cancer patients and 1140 cancer-free controls in a non-Hispanic white population and genotyped for these two polymorphisms. We found that the TS3'UTR, but not the TSER, variant was associated with the risk of lung cancer. Compared with homozygotes for the TS3'UTR 6 bp deletion (0bp/0bp), the 6bp/0bp+6bp/6bp genotypes were associated with a significantly increased risk of lung cancer [odds ratio (OR) = 1.52, 95% confidence interval (CI) = 1.12-2.06]. In stratification analysis the risk associated with the 0bp/6bp+6bp/6bp genotype was more pronounced in subjects who were >55 years old (OR = 1.57, 95% CI = 1.10-2.23), males (OR = 1.88, 95% CI = 1.22-2.89), current (OR = 2.04, 95% CI = 1.26-3.29) and heavy smokers (OR = 1.73, 95% CI = 1.10-2.70) and current drinkers (OR = 3.17, 95% CI = 1.78-5.64).Furthermore, significant gene-dietary interactions were found between TS3'UTR and alcohol consumption and between TSER and vitamin B(12) intake. In conclusion, the polymorphisms of TYMS are likely to contribute to the risk of lung cancer in non-Hispanic whites and interact with dietary factors in lung cancer development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15579479     DOI: 10.1093/carcin/bgh351

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  15 in total

1.  Sex-specific association of sequence variants in CBS and MTRR with risk for promoter hypermethylation in the lung epithelium of smokers.

Authors:  Kristina G Flores; Christine A Stidley; Amanda J Mackey; Maria A Picchi; Sally P Stabler; Jill M Siegfried; Tim Byers; Marianne Berwick; Steven A Belinsky; Shuguang Leng
Journal:  Carcinogenesis       Date:  2012-06-04       Impact factor: 4.944

2.  Folate metabolism-related gene polymorphisms and susceptibility to primary liver cancer in North China.

Authors:  Lian-Hua Cui; Yang Song; Hongzong Si; Fangzhen Shen; Min-Ho Shin; Hee Nam Kim; Jin-Su Choi
Journal:  Med Oncol       Date:  2011-09-29       Impact factor: 3.064

3.  Genetic variants in the enhancer region of the thymidylate synthase gene in the Chilean population.

Authors:  M Acuña; L Eaton; L Cifuentes; D Massardo
Journal:  Br J Clin Pharmacol       Date:  2006-06       Impact factor: 4.335

4.  Thymidylate synthase (TYMS) enhancer region genotype-directed phase II trial of oral capecitabine for 2nd line treatment of advanced pancreatic cancer.

Authors:  Colin D Weekes; Sujatha Nallapareddy; Michelle A Rudek; Alexis Norris-Kirby; Daniel Laheru; Antonio Jimeno; Ross C Donehower; Kathleen M Murphy; Manuel Hidalgo; Sharyn D Baker; Wells A Messersmith
Journal:  Invest New Drugs       Date:  2010-03-23       Impact factor: 3.850

5.  Thymidylate synthase polymorphisms and risk of conotruncal heart defects.

Authors:  Huiping Zhu; Wei Yang; Nathan Shaw; Spencer Perloff; Suzan L Carmichael; Richard H Finnell; Gary M Shaw; Edward J Lammer
Journal:  Am J Med Genet A       Date:  2012-08-07       Impact factor: 2.802

6.  Genetic variant rs16430 6bp > 0bp at the microRNA-binding site in TYMS and risk of sporadic breast cancer risk in non-Hispanic white women aged ≤ 55 years.

Authors:  Xiaoxiang Guan; Hongliang Liu; Jingfang Ju; Yangkai Li; Peng Li; Li-E Wang; Abenaa M Brewster; Thomas A Buchholz; Banu K Arun; Qingyi Wei; Zhensheng Liu
Journal:  Mol Carcinog       Date:  2013-10-26       Impact factor: 4.784

7.  Polymorphisms of cytosolic serine hydroxymethyltransferase and risk of lung cancer: a case-control analysis.

Authors:  Luo Wang; Jiachun Lu; Jiaze An; Qiuling Shi; Margaret R Spitz; Qingyi Wei
Journal:  Lung Cancer       Date:  2007-04-08       Impact factor: 5.705

8.  Association of thymidylate synthase gene with endometrial cancer risk in a Chinese population.

Authors:  Wang-Hong Xu; Ji-Rong Long; Wei Zheng; Zhi-Xian Ruan; Qiuyin Cai; Jia-Rong Cheng; Gen-Ming Zhao; Yong-Bing Xiang; Xiao-Ou Shu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-03       Impact factor: 4.254

9.  Polymorphisms in thymidylate synthase gene and susceptibility to breast cancer in a Chinese population: a case-control analysis.

Authors:  Xiangjun Zhai; Jun Gao; Zhibin Hu; Jinhai Tang; Jianwei Qin; Shui Wang; Xuechen Wang; Guangfu Jin; Jiyong Liu; Wenshen Chen; Feng Chen; Xinru Wang; Qingyi Wei; Hongbing Shen
Journal:  BMC Cancer       Date:  2006-05-25       Impact factor: 4.430

10.  Investigating multiple candidate genes and nutrients in the folate metabolism pathway to detect genetic and nutritional risk factors for lung cancer.

Authors:  Michael D Swartz; Christine B Peterson; Philip J Lupo; Xifeng Wu; Michele R Forman; Margaret R Spitz; Ladia M Hernandez; Marina Vannucci; Sanjay Shete
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.